Reviews
Systematic reviews
Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.
18 reviews, newest first
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support
Cochraneheadline outcomes only
14 findings
Distribution of initial caries lesions in relation to fixed orthodontic therapy. A systematic review and meta-analysis.
Non-Cochraneall outcomesaetiology33 included studies
9 findings
First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis
Cochraneheadline outcomes only
29 findings
Stem cell therapy for dilated cardiomyopathy
Cochraneheadline outcomes only
13 findings
Anti‐GD2 antibody‐containing immunotherapy postconsolidation therapy for people with high‐risk neuroblastoma treated with autologous haematopoietic stem cell transplantation
Cochraneheadline outcomes only
7 findings
Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease)
Cochraneheadline outcomes only
6 findings
Second‐line systemic therapy for metastatic colorectal cancer
Cochraneheadline outcomes only
32 findings
Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas
Cochraneheadline outcomes only
6 findings
Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation
Cochraneheadline outcomes only
7 findings
High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
Cochraneheadline outcomes only
4 findings
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
Cochraneheadline outcomes only
7 findings
Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
Cochraneheadline outcomes only
16 findings
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
Cochraneheadline outcomes only
7 findings
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
Cochraneheadline outcomes only
7 findings
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
Cochraneheadline outcomes only
21 findings
High‐dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
Cochraneheadline outcomes only
5 findings
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation
Cochraneheadline outcomes only
17 findings
High‐dose therapy with autologous stem cell transplantation versus chemotherapy or immuno‐chemotherapy for follicular lymphoma in adults
Cochraneheadline outcomes only
6 findings